Impact of Tensor Fascia Lata Stretch on Vastus Medialis Obliqus Activity

December 14, 2024 updated by: Tasneem Khaled Fouad Abdelghany, Ahram Canadian University

Impact of Tensor Fascia Lata Stretch Prior to Squat on Vastus Medialis Obliqus Activity in Patellofemoral Pain Syndrome

Patellofemoral pain syndrome (PFPS) is one of the most typical causes of anterior knee pain in adolescents and young adults under the age of 50.It is believed that imbalanced action between quadriceps components, is the most contributing cause of PFPS.Investigating exercises that increase VMO muscle activation and enhance the ratio between VMO and VL have been a standardized target in literature.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Participants will have the assessed limb ready by shaving the hair on thigh and using alcohol swabs to clean the area from any residues.

For the VMO, a surface EMG electrode will be placed 4 cm superior and 4 cm medial to the supromedial boarder of patella at approximately 55 degrees to the long axis of the femur. As for the VL, the electrode will be placed 10 cm superior and 6-8 cm lateral to the superior lateral boarder of the patella and orientated 15 degrees to the vertical. All electrodes are self-adhesive (Figure 8) and will be connected to EMG sensors that will be attached and secured by double-sided tape.Each participant will perform three consecutive squats with 5 seconds interval break between each repetition. The squat depth will be kept at 50 degrees knee flexion. Mean muscle activity from three squat repetitions of VMO and VL is recorded and VMO:VL ratio is calculated. Afterward, each participant will perform the TFL stretch and repeat the three squats again.

Study Type

Observational

Enrollment (Estimated)

37

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

patients referred from orthopedic surgeon with diagnosis of PFPS

Description

Inclusion Criteria:

  1. Both genders.
  2. Body mass index (BMI) ranges from 18.5 to 29.9.
  3. Age ranges between 18 and 30 years old.
  4. Experience nontraumatic anterior knee pain.
  5. Pain with any two activities, including running, jumping, squatting, kneeling, stair ascent/descent or prolonged sitting.
  6. Having at least one positive PFPS clinical tests including, patellofemoral compression, patellofemoral gliding or resistive quadriceps setting

Exclusion Criteria:

  1. Coexisting pathology around the knee, including patellar subluxation or dislocation.
  2. Previous knee surgery.
  3. Suspicion of patellar tendinopathy, with strong consideration of pain localised to the patellar tendon.
  4. Patients didn't receive physiotherapy treatment or use of non-steroidal anti-inflammatory drugs for knee pain in the previous 3 months.
  5. Any neurological or rheumatic disorders
  6. Pain intensity more than 5 (based on visual analogue scale)
  7. Hip and ankle pathology.
  8. BMI more than 30%.
  9. Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VMO muscle activity
Time Frame: During the procedure
VMO muscle activity during squat is assessed by EMG device
During the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VMO to VL ratio
Time Frame: Immediately after the procedure
Ratio between VMO and VL activity during squat
Immediately after the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Enas Fawzy, Professor, Cairo university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2024

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

December 7, 2024

First Submitted That Met QC Criteria

December 14, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 14, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Patellofemoral Pain syndrome

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain Syndrome

Clinical Trials on Stretch Exercise

Subscribe